Literature DB >> 1301958

An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.

S Shore1, J Tomczak, E E Grebner, R Myerowitz.   

Abstract

The Ashkenazi Jewish population is enriched for carriers of a fatal form of Tay-Sachs disease, a recessive inherited disorder caused by mutations in the alpha-chain of the lysosomal enzyme beta-hexosaminidase A. Approximately 20% of the Ashkenazi carriers harbor a splice junction defect while about 78% bear a 4 base pair (bp) insertion. However, the Ashkenazi Jewish patient used in the original description of the 4 bp insertion carried this lesion in only 1 allele and was negative for the splice junction mutation. We cloned the insertion negative allele and by sequence analysis of the exons found a point mutation in exon 11 that results in substitution of Trp392 with a premature termination codon. Nine Ashkenazi Jewish carriers that tested negative for the major and minor mutations as well as for a lesion causing an adult form of Tay-Sachs disease did not carry the base change defect, suggesting that it may be a recent and/or rare mutation. This finding also indicates that screening the Ashkenazi population solely by recombinant DNA methods for the splice junction, 4 bp insertion, and adult mutations may result in occasional false negatives.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1301958     DOI: 10.1002/humu.1380010606

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  3 in total

1.  Nonsense-mediated decay of human HEXA mRNA.

Authors:  K S Rajavel; E F Neufeld
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  HLA-H and associated proteins in patients with hemochromatosis.

Authors:  E Beutler; C West; T Gelbart
Journal:  Mol Med       Date:  1997-06       Impact factor: 6.354

3.  Three novel mutations in Iranian patients with Tay-Sachs disease.

Authors:  Solmaz Jamali; Nasim Eskandari; Omid Aryani; Shadab Salehpour; Talieh Zaman; Behnam Kamalidehghan; Massoud Houshmand
Journal:  Iran Biomed J       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.